230 related articles for article (PubMed ID: 30133331)
21. The role of the tumor suppressor RUNX3 in giant cell tumor of the bone.
Han YX; Liang DY
Int J Oncol; 2012 Mar; 40(3):673-8. PubMed ID: 22076387
[TBL] [Abstract][Full Text] [Related]
22. Epigenetic regulation of bone morphogenetic protein-6 gene expression in breast cancer cells.
Zhang M; Wang Q; Yuan W; Yang S; Wang X; Yan JD; Du J; Yin J; Gao SY; Sun BC; Zhu TH
J Steroid Biochem Mol Biol; 2007; 105(1-5):91-7. PubMed ID: 17574840
[TBL] [Abstract][Full Text] [Related]
23. Loss of RUNX3 is significantly associated with advanced tumor grade and stage in endometrial cancers.
Jeong D; Kim H; Ryu A; Sunwoo J; Choi SD; Nam GH; Jeon S
Mol Med Rep; 2018 Jun; 17(6):8173-8179. PubMed ID: 29693143
[TBL] [Abstract][Full Text] [Related]
24. Hypermethylation of RUNX3 but not WIF1 gene and its association with stage and nodal status of tongue cancers.
Supic G; Kozomara R; Jovic N; Zeljic K; Magic Z
Oral Dis; 2011 Nov; 17(8):794-800. PubMed ID: 21819494
[TBL] [Abstract][Full Text] [Related]
25. Methylation of the RUNX3 promoter as a potential prognostic marker for bladder tumor.
Kim EJ; Kim YJ; Jeong P; Ha YS; Bae SC; Kim WJ
J Urol; 2008 Sep; 180(3):1141-5. PubMed ID: 18639281
[TBL] [Abstract][Full Text] [Related]
26. Stepwise cumulation of RUNX3 methylation mediated by Helicobacter pylori infection contributes to gastric carcinoma progression.
Lu XX; Yu JL; Ying LS; Han J; Wang S; Yu QM; Wang XB; Fang XH; Ling ZQ
Cancer; 2012 Nov; 118(22):5507-17. PubMed ID: 22576578
[TBL] [Abstract][Full Text] [Related]
27. [Demethylation of estrogen receptor gene and its re-expression in estrogen receptor-negative breast].
Wang R; Li LW; Wang RL; Fan QX; Zhao PR; Wang LX; Lu SH
Zhonghua Zhong Liu Za Zhi; 2006 Dec; 28(12):894-7. PubMed ID: 17533738
[TBL] [Abstract][Full Text] [Related]
28. RUNX3 inactivation by point mutations and aberrant DNA methylation in bladder tumors.
Kim WJ; Kim EJ; Jeong P; Quan C; Kim J; Li QL; Yang JO; Ito Y; Bae SC
Cancer Res; 2005 Oct; 65(20):9347-54. PubMed ID: 16230397
[TBL] [Abstract][Full Text] [Related]
29. [Promoter methylation and expression of Runx3 gene in gastric cancer].
Li LY; Li JK; Shen Y; Yu L; Zhang JH
Zhonghua Wei Chang Wai Ke Za Zhi; 2008 Jul; 11(4):379-82. PubMed ID: 18636364
[TBL] [Abstract][Full Text] [Related]
30. Epigenetic mechanisms regulate the prostaglandin E receptor 2 in breast cancer.
To SQ; Takagi K; Miki Y; Suzuki K; Abe E; Yang Y; Sasano H; Simpson ER; Knower KC; Clyne CD
J Steroid Biochem Mol Biol; 2012 Nov; 132(3-5):331-8. PubMed ID: 22929011
[TBL] [Abstract][Full Text] [Related]
31. Frequent hemizygous deletion at 1p36 and hypermethylation downregulate RUNX3 expression in human lung cancer cell lines.
Yanada M; Yaoi T; Shimada J; Sakakura C; Nishimura M; Ito K; Terauchi K; Nishiyama K; Itoh K; Fushiki S
Oncol Rep; 2005 Oct; 14(4):817-22. PubMed ID: 16142337
[TBL] [Abstract][Full Text] [Related]
32. RUNX3 methylation as a predictor for disease progression in patients with non-muscle-invasive bladder cancer.
Yan C; Kim YW; Ha YS; Kim IY; Kim YJ; Yun SJ; Moon SK; Bae SC; Kim WJ
J Surg Oncol; 2012 Mar; 105(4):425-30. PubMed ID: 22311819
[TBL] [Abstract][Full Text] [Related]
33. Clinical significance of determining the hypermethylation of the RUNX3 gene promoter and its cohypermethylation with the BRCA1 gene for patients with breast cancer.
Rossokha Z; Fishchuk L; Lobanova O; Vershyhora V; Medvedieva N; Cheshuk V; Vereshchako R; Podolska S; Gorovenko N
J Cancer Res Clin Oncol; 2023 Oct; 149(13):11919-11927. PubMed ID: 37420018
[TBL] [Abstract][Full Text] [Related]
34. Tumor suppressor function of RUNX3 in breast cancer.
Chen LF
J Cell Biochem; 2012 May; 113(5):1470-7. PubMed ID: 22275124
[TBL] [Abstract][Full Text] [Related]
35. Promoter hypermethylation of the SFRP2 gene is a high-frequent alteration and tumor-specific epigenetic marker in human breast cancer.
Veeck J; Noetzel E; Bektas N; Jost E; Hartmann A; Knüchel R; Dahl E
Mol Cancer; 2008 Nov; 7():83. PubMed ID: 18990230
[TBL] [Abstract][Full Text] [Related]
36. Frequent loss of RUNX3 expression by promoter hypermethylation in gastric carcinoma.
Oshimo Y; Oue N; Mitani Y; Nakayama H; Kitadai Y; Yoshida K; Ito Y; Chayama K; Yasui W
Pathobiology; 2004; 71(3):137-43. PubMed ID: 15051926
[TBL] [Abstract][Full Text] [Related]
37. Inactivation of p16, RUNX3, and HPP1 occurs early in Barrett's-associated neoplastic progression and predicts progression risk.
Schulmann K; Sterian A; Berki A; Yin J; Sato F; Xu Y; Olaru A; Wang S; Mori Y; Deacu E; Hamilton J; Kan T; Krasna MJ; Beer DG; Pepe MS; Abraham JM; Feng Z; Schmiegel W; Greenwald BD; Meltzer SJ
Oncogene; 2005 Jun; 24(25):4138-48. PubMed ID: 15824739
[TBL] [Abstract][Full Text] [Related]
38. Alteration in the expression of MGMT and RUNX3 due to non-CpG promoter methylation and their correlation with different risk factors in esophageal cancer patients.
Saikia S; Rehman AU; Barooah P; Sarmah P; Bhattacharyya M; Deka M; Deka M; Goswami B; Husain SA; Medhi S
Tumour Biol; 2017 May; 39(5):1010428317701630. PubMed ID: 28468586
[TBL] [Abstract][Full Text] [Related]
39. Epigenetic changes in localized gastric cancer: the role of RUNX3 in tumor progression and the immune microenvironment.
Llorca-Cardeñosa MJ; Fleitas T; Ibarrola-Villava M; Peña-Chilet M; Mongort C; Martinez-Ciarpaglini C; Navarro L; Gambardella V; Castillo J; Roselló S; Navarro S; Ribas G; Cervantes A
Oncotarget; 2016 Sep; 7(39):63424-63436. PubMed ID: 27566570
[TBL] [Abstract][Full Text] [Related]
40. MicroRNA-148a can regulate runt-related transcription factor 3 gene expression via modulation of DNA methyltransferase 1 in gastric cancer.
Zuo J; Xia J; Ju F; Yan J; Zhu A; Jin S; Shan T; Zhou H
Mol Cells; 2013 Apr; 35(4):313-9. PubMed ID: 23549984
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]